Formulation and Evaluation of Bilayer Sustained Release Tablets of Salbutamol and Theophylline

DOI:

https://doi.org/10.37285/ijpsn.2009.2.3.7

Authors

  • R. Nagaraju
  • Rajesh Kaza

Abstract

Salbutamol and theophylline are available in conventional dosage forms, administered four times a day, leading to saw tooth kinetics and resulting in ineffective therapy. The combination of these two drugs in a single dosage form will enhance the patient compliance and prolong bronchodilation. Various polymers, such as hydroxy propyl methylcellulose K4M (HPMC- K4M), hydroxy propyl methylcellulose K100M (HPMC- K100M), xanthan gum, ethyl cellulose and hydroxy propyl methylcellulose phthalate (HPMC-P) were studied. HPMC-P and HPMC- K4M were found to be best in controlling the release. In-vitro dissolution studies were carried out for all the bi-layered tablets developed using USP dissolution apparatus type 2 (paddle). It was found that the tablet FB15-FW3 showed 50% release of salbutamol in first hour and the remaining was released for eight hours. However, theophylline was found to be released as per the USP specifications. The IR spectrum was taken for FB15-FW3 formulation and it revealed that there is no disturbance in the principal peaks of pure drugs salbutamol and theophylline. This further confirms the integrity of pure drugs and no incompatibility of them with excipients. Also, formulation of FB15-FW3 has shown required release pattern and complies with all the evaluated parameters and comparable to the marketed formulation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Sustained release, Bi-layer tablets, Formulation, Evaluation

Downloads

Published

2009-11-30

How to Cite

1.
R. Nagaraju, Kaza R. Formulation and Evaluation of Bilayer Sustained Release Tablets of Salbutamol and Theophylline. Scopus Indexed [Internet]. 2009 Nov. 30 [cited 2024 Oct. 13];2(3):638-46. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/632

Issue

Section

Research Articles

References

Abrens RC, Joad JP, Weinberger MM, Journal of Clinical Immunology; 1987; 79: 78-85.

Bhaskaran S, Dhir SS, Indian Journal of Pharmaceutical Sciences; 1995; 57: 240-242.

Harrison LI, Kehc CR, Journal of Pharmaceutical Sciences; 1994; 83:1171-1173.

Katikaneni PR, Upadrashta SM, Ethylcellulose matrix controlled release tablets of a water-soluble drug, International Journal of Pharmaceutical Sciences; 1995; 123: 119-125.

Libermann HA, Lachman L, Schwartz JB, Pharmaceutical Dosage Forms: Tablets 2 nd Edition Vol: 1, 274-278 (1990).

Libermann HA, Lachman L, Schwartz JB, Pharmaceutical Dosage Forms: Tablets 2 nd Edition Vol: 1, 278-279 (1990).

Murthy NS, Rani S, Hiramath R, The internet Journal of Pharmacology, 2001, Vol. 1, No.1, 2.

Muthu MS, Singh S, Soni R, Formulation and evaluation of Bilayer tablets containing some Anti-inflammatory drugs Indian Pharmaceutical Congress 56: Scientific abstracts pp. 7 (2004).

Naidu MUR, Ramesh Kumar T, Ravishekhar K, Indian Journal of Pharmaceutical Sciences; 1990; 52: 87-90.

Ochoa L, Pedraz JL, Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer, J Pharm Pharmaceut Sci (www.cspscanada.org). 2005; 8: 132-140.

Pandey S, Pal M, Singh UV, Indian Journal of Pharmaceutical Sciences; 1998; 60: 241-243.

Pawar AP, Paradkar AR, Dana SB, The Eastern Pharmacist, 1995, Vol: XXXVIII No. 456: 123-125.

S Sujata, S Shahe, Studies on the application of Hupu Gum in the design of Flaoting Drug Delivery systems for theophylline, 57th Indian pharmaceutical congress scientific abstracts, pp.121 (2005).

Slchioo C, Robinson JR, Remington’s pharmaceutical sciences, 17th edition, 1985; 1644-1653.

Solinís MA, Cruz YD, Hernández RM, Release of ketoprofen enantiomers from HPMC K100M matrices diffusion studies. International Journal of Pharmaceutics 2002; 239 (1-2): 61-68.

Solinís MA, Pedraz JL, Release of salbutamol sulfate enantiomers from hydroxypropyl methylcellulose matrices. International Journal of Pharmaceutics, 2002; 239: 61-68.

Torres D, Garcia-Encina Formulation and in vitro evaluation of HPMCP-microencapsulated drug-resin complexes for sustained release of diclofenac. International Journal of Pharmaceutical Sciences; 1995; 121: 239-243.

USP 25 NF 21 2002, Asian Edition, 1684-1686.

V Alagarswamy and V Sivakumar, Design and development of controlled release microspheres of theophylline, 57th Indian pharmaceutical congress scientific abstracts, pp. 119 (2005).

Yeole PG, Galgatte UC. Design and evaluation of Xanthan gum-based sustained release Matrix tablets of Diclofenac sodium, Indian Journal of Pharmaceutical Sciences. 2006; 68:185-189